1. Home
  2. MRVI vs NBH Comparison

MRVI vs NBH Comparison

Compare MRVI & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • NBH
  • Stock Information
  • Founded
  • MRVI 2014
  • NBH 2002
  • Country
  • MRVI United States
  • NBH United States
  • Employees
  • MRVI N/A
  • NBH N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • NBH Finance/Investors Services
  • Sector
  • MRVI Health Care
  • NBH Finance
  • Exchange
  • MRVI Nasdaq
  • NBH Nasdaq
  • Market Cap
  • MRVI 312.4M
  • NBH 287.0M
  • IPO Year
  • MRVI 2020
  • NBH N/A
  • Fundamental
  • Price
  • MRVI $2.20
  • NBH $9.81
  • Analyst Decision
  • MRVI Hold
  • NBH
  • Analyst Count
  • MRVI 10
  • NBH 0
  • Target Price
  • MRVI $6.84
  • NBH N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • NBH 85.9K
  • Earning Date
  • MRVI 08-11-2025
  • NBH 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • NBH 4.34%
  • EPS Growth
  • MRVI N/A
  • NBH N/A
  • EPS
  • MRVI N/A
  • NBH 0.12
  • Revenue
  • MRVI $241,856,000.00
  • NBH N/A
  • Revenue This Year
  • MRVI N/A
  • NBH N/A
  • Revenue Next Year
  • MRVI $10.70
  • NBH N/A
  • P/E Ratio
  • MRVI N/A
  • NBH $87.04
  • Revenue Growth
  • MRVI N/A
  • NBH N/A
  • 52 Week Low
  • MRVI $1.67
  • NBH $8.75
  • 52 Week High
  • MRVI $9.95
  • NBH $11.01
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 42.78
  • NBH 47.14
  • Support Level
  • MRVI $1.99
  • NBH $9.78
  • Resistance Level
  • MRVI $2.40
  • NBH $9.85
  • Average True Range (ATR)
  • MRVI 0.16
  • NBH 0.10
  • MACD
  • MRVI -0.06
  • NBH 0.01
  • Stochastic Oscillator
  • MRVI 25.15
  • NBH 42.86

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.

Share on Social Networks: